Carregant...
Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events
BACKGROUND: Aspirin is the prophylactic antiplatelet drug of choice for people with cardiovascular disease. Adding a second antiplatelet drug to aspirin may produce additional benefit for people at high risk and people with established cardiovascular disease. This is an update to a previously publis...
Guardat en:
| Publicat a: | Cochrane Database Syst Rev |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Ltd
2017
|
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6486024/ https://ncbi.nlm.nih.gov/pubmed/29240976 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD005158.pub4 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|